These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 21712008

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
    McKenna KE, Whittaker S, Rhodes LE, Taylor P, Lloyd J, Ibbotson S, Russell-Jones R, British Photodermatology Group, UK Skin Lymphoma Group.
    Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J.
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of 8-methoxypsoralen during extracorporeal photopheresis.
    Shephard SE, Nestle FO, Panizzon R.
    Photodermatol Photoimmunol Photomed; 1999 Apr; 15(2):64-74. PubMed ID: 10321518
    [Abstract] [Full Text] [Related]

  • 11. Extracorporeal photochemotherapy.
    Maeda A.
    J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
    Darvay A, Salooja N, Russell-Jones R.
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
    [Abstract] [Full Text] [Related]

  • 17. Retinal toxic reactions following photopheresis.
    Vagace JM, Gervasini G, Morais F, Benitez J, Alonso N, de Argila D, Arranz I, Bajo R.
    Arch Dermatol; 2007 May; 143(5):622-5. PubMed ID: 17515512
    [Abstract] [Full Text] [Related]

  • 18. Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art.
    Martino M, Fedele R, Cornelio G, Moscato T, Imbalzano L, Ressa G, Massara E, Bresolin G.
    Expert Opin Biol Ther; 2012 Aug; 12(8):1017-30. PubMed ID: 22587646
    [Abstract] [Full Text] [Related]

  • 19. Extracorporeal photopheresis: a review.
    Oliven A, Shechter Y.
    Blood Rev; 2001 Jun; 15(2):103-8. PubMed ID: 11409910
    [Abstract] [Full Text] [Related]

  • 20. Treatment of graft versus host disease (GVHD) by photopheresis?
    Schooneman F, Claise C.
    Transfus Sci; 1996 Dec; 17(4):527-36. PubMed ID: 10168550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.